These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 10559559)
1. A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease. Hesse C; Bogdanovic N; Davidsson P; Blennow K Dement Geriatr Cogn Disord; 1999; 10(6):452-9. PubMed ID: 10559559 [TBL] [Abstract][Full Text] [Related]
2. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
3. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505 [TBL] [Abstract][Full Text] [Related]
4. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue. Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I Dement Geriatr Cogn Disord; 1999; 10(4):252-7. PubMed ID: 10364641 [TBL] [Abstract][Full Text] [Related]
5. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Richey PL; Siedlak SL; Smith MA; Perry G Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621 [TBL] [Abstract][Full Text] [Related]
8. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Sparks DL Ann N Y Acad Sci; 1997 Sep; 826():128-46. PubMed ID: 9329686 [TBL] [Abstract][Full Text] [Related]
9. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600 [TBL] [Abstract][Full Text] [Related]
10. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease. Amponsah AE; Feng B; Guo R; Zhang W; He J; Kong D; Dong T; Ma J; Cui H Rev Neurosci; 2020 Aug; 31(6):589-603. PubMed ID: 32364519 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889 [TBL] [Abstract][Full Text] [Related]
13. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Lovell MA; Smith JL; Xiong S; Markesbery WR Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263 [TBL] [Abstract][Full Text] [Related]
14. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207 [TBL] [Abstract][Full Text] [Related]
15. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517 [TBL] [Abstract][Full Text] [Related]
17. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Glöckner F; Meske V; Ohm TG Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Pirttilä T; Soininen H; Mehta PD; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kim KS; Kosunen O; Winblad B; Riekkinen P; Wisniewski HM Neurobiol Aging; 1997; 18(1):121-7. PubMed ID: 8983040 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114 [TBL] [Abstract][Full Text] [Related]